Cencora, Inc.

COR ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $1.55B $1.51B $1.75B $1.70B $1.54B $-3.41B $855.4M $1.66B
Depreciation & Amortization $1.05B $1.09B $963.9M $693.9M $505.2M $391.1M $462.4M $465.1M
Depreciation $501.3M $448.2M $418.8M $390.6M $326.7M $290.7M $321.1M $318.5M
Amortization $556.9M $663.5M $553.6M $307.3M $178.3M $110.9M $167.4M $181.2M
Stock-Based Compensation $148.0M $148.0M $124.6M $93.4M $99.6M $74.4M $58.9M $62.3M
Net Cash from Operating Activities $3.88B $3.48B $3.91B $2.70B $2.67B $2.21B $2.34B $1.41B
Investing Activities
Capital Expenditures $668.0M $487.2M $458.4M $496.3M $438.2M $369.7M $310.2M $336.4M
Business Acquisitions $4.10B $69.8M $1.41B $133.8M $5.56B $0 $64.0M $785.3M
Net Cash from Investing Activities $-4.98B $-618.1M $-2.60B $-368.4M $-6.14B $-379.9M $-375.8M $-1.11B
Financing Activities
Dividends Paid $437.1M $416.2M $398.8M $391.7M $366.6M $343.6M $339.0M $333.0M
Stock Repurchases $435.5M $1.49B $1.18B $483.7M $82.2M $420.4M $674.0M $639.2M
Net Cash from Financing Activities $2.25B $-2.33B $-2.22B $-1.75B $1.95B $-603.6M $-1.09B $-242.9M
Net Change in Cash $1.10B $545.0M $-840.7M $523.4M $-1.53B $1.22B $881.7M $57.4M
Free Cash Flow $3.21B $3.00B $3.45B $2.21B $2.23B $1.84B $2.03B $1.07B
← Newer Page 1 of 3 Older →